Tokyo Gas Co. (TOG.F, 9531.T) reported fiscal year profit attributable to owners of parent of 226.9 billion yen, up 205.8% from last year. Basic earnings per share was 654.76 yen compared to 192.22 yen. For the fiscal year ended March 31, 2026, net sales were 2.8 trillion yen, up 7.5% from last year....
Aisin Corp. (ASEKY.PK, 7259.T) Tuesday reported significantly higher profit in fiscal 2026 with revenue growth. Further, the firm announced higher dividend, and issued fiscal 2027 outlook, expecting lower net profit, but higher operating profit. In Tokyo, the shares were gaining around 1.04 percent,...
Japan Exchange Group (OSK.F, 8697.T) reported fiscal year net income attributable to owners of the parent company of 79.1 billion yen, an increase of 29.5% from prior year. Basic earnings per share was 76.81 yen compared to 58.72 yen. Operating income was 116.3 billion yen, up 29.0%. For the fiscal...
DENSO Corp. (DNZOY.PK, 6902.T), a Japanese automotive components manufacturer, reported Tuesday higher profit and revenues for fiscal 2026. Further, the company announced higher dividend, and issued fiscal 2027 outlook, expecting weak profit, but higher revenues. In Tokyo, the shares were losing around...
Toyota Industries (TAH.F, 6201.T) reported fiscal 2026 profit attributable to owners of the parent of 223.8 billion yen, down 14.7% from last year. Earnings per share was 744.75 yen compared to 856.96 yen. Operating profit was 137.0 billion yen, down 38.2%. For the fiscal year ended March 31, 2026,...
Mapletree Pan Asia Commercial Trust (N2IU.SI) reported a fourth quarter loss to unitholders of S$26.7 million compared to profit of S$395.3 million, prior year. Loss per unit, in cents, was 0.51 compared to profit of 7.50. Fourth quarter gross revenue was S$210.74 million, down 5.5% from prior year....
Samsung SDI Co. (006400.KS) posted a first quarter net loss to owners of the parent of 28 billion Korean won compared to a loss of 221 billion won, prior year. Operating loss narrowed to 156 billion won compared to a loss of 434 billion won. First quarter revenue increased to 3.58 trillion Korean...
The Real Brokerage Inc. (REAX), a technology-powered real estate brokerage, and RE/MAX Holdings, Inc. (RMAX), a real estate franchisor on Monday announced that they have entered into a definitive agreement where Real Brokerage will acquire RE/MAX, LLC or REMAX, a unit of RE/MAX Holdings, to form a new...
Adial Pharmaceuticals, Inc. (ADIL) on Monday said it has submitted its AD04 application for consideration under the U.S. Food and Drug Administration Commissioner's National Priority Voucher Pilot Program (CNPV). The program allows companies to receive an expedited review of a drug application, including...
Oil and gas major Shell Plc (SHEL, SHEL.L) Monday announced that it has entered into a definitive agreement to acquire Canadian energy company ARC Resources Ltd. (AETUF, ARX.TO) in cash and stock deal with equity value of around $13.6 billion. Under the deal terms, ARC shareholders will receive C$8.20...
Mirum Pharmaceuticals Inc. (MIRM) on Monday said the primary endpoint was met in the Phase 2b portion of its AZURE-1 study evaluating brelovitug for the treatment of chronic hepatitis delta virus (HDV). At Week 24, brelovitug showed strong antiviral activity, with 100% of patients in the 300 mg weekly...
CorMedix Inc. (CRMD), Monday announced positive Phase III topline results from the global ReSPECT clinical trial, evaluating REZZAYO for prophylaxis of invasive fungal diseases in adult patients undergoing allogeneic hematopoietic stem cell transplantation. The multicenter, randomized, double-blind...
Jazz Pharmaceuticals plc (JAZZ) on Monday said that the U.S. Food and Drug Administration (FDA) has granted priority review to its supplemental Biologics License Application for Ziihera for the first-line treatment of adults with HER2-positive gastric, gastroesophageal junction (GEJ), or gastroesophageal...
AbbVie Inc. (ABBV) on Monday said it has submitted an application to the U.S. Food and Drug Administration seeking approval for a subcutaneous induction regimen of SKYRIZI for adults with moderately to severely active Crohn's disease. The filing is backed by positive Phase 3 AFFIRM study results,...
Thermo Fisher Scientific Inc. (TMO), on Monday, announced that it has signed a definitive agreement to sell its microbiology business to Astorg. The transaction is approximately $1.075 billion, consisting of cash and a $50 million seller note. The deal is expected to close in the second half of...
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.